Page results
-
Two clinicians with close links to UCLH and UCL have been appointed to be National Clinical Directors (NCD) by NHS England (NHSE) for 2024.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
Dr Hotton is a consultant neurologist with a special interest in movement disorders and the neurological care of patients with central nervous system tumours.
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
CTOS 2023 Dublin Physicians, residents, colleagues, and healthcare professionals who specialize in sarcomas come together during this meeting to discuss new developments, treatments, and advancements in the field.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
Information on schistosomiasis for users of the RESPOND refugee health service.
-
3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
-
The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.
File results
-
FOI/2024/0158 - Procedures cancelled due to issues with defective diagnostic equipment
-
FOI/2024/0169 - Medical emergency protocols
-
FOI/2024/0171 - Dermatology consultants
-
FOI/2024/0182 - Women diagnosed with Endometriosis 2019 to 2023
-
FOI/2024/0211 - Acute admissions of women aged 18 to 35 for gynaecology, urology or general surgery 2013-2023
-
FOI/2024/0215 - Agency nursing shifts Band 2 and Band 5 from April 2023 to March 2024
-
FOI/2024/0237 - Staff access to NHS intranet
-
FOI/2024/0238 - Haematology and immunoglobulin treatments
-
FOI/2024/0243 - Pathology laboratory service/ information system at Trust
-
FOI/2024/0255 - Ingenica stock management system in theatres